Noveko International Inc. discloses conclusive results of the effectiveness tests of the Noveko(TM) antimicrobial air filter for hog farms - Proven ability to prevent airborne introduction to swine facilities of PRRS virus - the virus causing the most costly disease for the North American swine industry

    The study was jointly conducted by Dr. Laura Batista of the Faculty of
    Veterinary Medicine of the Université de Montréal and the Centre de
    développement du porc du Québec inc. (CDPQ)

    (EKO - TSX Venture Exchange)

    MONTREAL, Dec. 10 /CNW Telbec/ - NOVEKO INTERNATIONAL INC. ("Noveko" or
the "Company") is pleased to announce the conclusive results of a complete
series of tests proving that its patented antimicrobial air filter can prevent
airborne introduction to swine facilities of the virus causing the porcine
reproductive and respiratory syndrome (PRRS). According to the Faculty of
Veterinary Medicine of the Université de Montréal (2007)(1), this virus
infects up to 90% of swine herds in certain regions having a large animal
population and causes annual losses of approximately $150 million for the
Canadian swine industry and US$560 million for the swine industry in the
United States(2). These results show that the subsidiary Noveko Inc. has
developed a new means of defence against porcine viruses.

    A scientific study entirely conducted by specialized external bodies

    Initiated in April 2007, the series of tests was jointly conducted by the
Faculty of Veterinary Medicine of the Université de Montréal and the Centre de
développement du porc du Québec inc. The goal of the study was to assess the
effectiveness of the Noveko(TM) antimicrobial air filter in preventing
airborne transmission of the PRRS virus in the presence of hogs. The
experimental setup allowed more than ten million PRRS viruses to be sprayed
over a period of five minutes in a test chamber; animals in an adjacent
disinfected room, connected to the test chamber by the filtration system, were
then exposed to these PRRS viruses for six hours. The air renewal rate in
these chambers was about ten times greater than a normal air entry on a
livestock farm and the quantity of ten million viruses transmitted by spraying
was much higher than for contamination under real conditions. This virus is
highly infectious and few viral particles are needed to infect an animal;
intranasal or intramuscular(3) exposure to ten particles or less is
sufficient. The blood analyses showed that 95% of the exposed animals (19 hogs
out of 20) were not contaminated in the trials. Obtained under extreme
experimental conditions, these results suggest that the Noveko(TM)
antimicrobial air filter has a superior potential to prevent airborne
transmission of the PRRS virus under the usual conditions on a hog farm.
    The project team members, who included Dr. Laura Batista of the Faculty
of Veterinary Medicine of the Université de Montréal, Françis Pouliot, Eng.,
MBA, Valérie Dufour, M.Sc. and Michel Morin, CDPQ Agroeconomist, indicated
that: "The use of a filter such as the one manufactured by Noveko marks a
significant breakthrough in air filtration in swine facilities, considering
its effectiveness in preventing airborne introduction to swine facilities of
the PRRS virus, its affordable cost and its easy installation on conventional
livestock farms. The air filtration system developed by Noveko has the
potential to be incorporated into a global biosafety protocol that should be
implemented on breeding sites to significantly reduce the risk of transmitting
diseases that could have devastating effects on herds."
    "The scope and economic impact of diseases in swine breeding worldwide,
the novelty of the virucidal-bactericidal fibres of Noveko's technology, the
test results and the filtration system's affordable cost prove that there is
good potential for this type of filter in swine breeding for the mass market,"
they added.

    An effective and durable three-layer filtration system that is economical
    and easy to use

    The filtration system has three layers: - the first traps crude particles
- the second consisting of a patented virucidal-bactericidal fibre includes
three layers of filters to trap finer particles - and the third consisting of
seven layers of the same matrix maximizes the effect of the
virucidal-bactericidal agents while minimizing the cleaning frequency. The
estimated lifespan of the filter is two years and that of the casing is ten
years. For example, over an estimated lifespan of ten years, the filter
utilization costs in a maternity would be $1.76(4) per weaned piglet, i.e.
about the price of a PRRSV vaccine.
    "It has been proven that our filter, designed specifically for difficult
conditions on farms, is an effective and economical means of preventing
devastating airborne diseases on livestock farms. Remember that given the
magnitude of the problems in the swine industry, the Table filière porcine du
Québec, in its 2005-2009 strategic plan, had put the emphasis on protecting
livestock against diseases having a major economic impact, indicating the need
for means to reduce the impact of diseases in swine breeding. Our
antimicrobial air filter represents also offers excellent potential to prevent
the transmission of other airborne pathogens in other types of breeding. We
are therefore ready to market it worldwide," said André Leroux, Chairman of
the Board and Chief Executive Officer of Noveko International Inc.
    Alain Bolduc, President and Chief Operating Officer of Noveko
International Inc., pointed to the contribution of each of Noveko's partners
to this project, specifically the Ministère de l'Agriculture, des Pêcheries et
de l'Alimentation du Québec through its Programme d'appui financier aux
associations de producteurs designees, Volet "Initiatives" - the Faculty of
Veterinary Medicine of the Université de Montréal - the Fédération des
producteurs de porcs du Québec - the Centre de développement du porc du Québec
inc. - Boehringer Ingelheim Vetmedica and the Société des éleveurs de porcs du
    "The results of these tests conducted under extreme experimental
conditions, proving that our filtration system can prevent the introduction of
pathogens such as viruses, pave the way for our development of the air filter
market for humans, especially for hospitals and other healthcare
institutions," added Alain Bolduc.


    Noveko International Inc. currently has four subsidiaries: S.A.S. ECM,
Noveko Inc., Laboratoire SyMa Inc. ("SyMa") and Bolduc Leroux Inc. ("BLI").
ECM specializes in the design and marketing of portable real-time ultrasound
scanners for use in veterinary and human medicine. Noveko Inc. develops the
Company's biomedical and environmental business, specifically its patented
antimicrobial filtration technology and derivative products (Noveko(TM)
antimicrobial face masks and air filters). SyMa specializes in the manufacture
of sanitizers, more specifically the antimicrobial products (for hands, feet
and surfaces) sold under the Azuro(TM) trademark. For its part, BLI
specializes in the custom processing and distribution of steel products based
on client specifications and designs. It has also developed and markets a line
of downdraft particle extraction tables for various markets. Operating since
September 2002, the Company was listed on the TSX Venture Exchange on
February 3, 2004.

    (1) FMV. 2007. Formation et recherche en santé animale : Préparer
        l'avenir de l'agriculture et de l'agroalimentaire québécois. Brief
        presented by Jean Sirois, Dean, Commission on the Future of
        Agriculture and Agri-Food in Quebec, 14 p.

    (2) Neumann, E.J., Kliebenstein, J.B., Johnson, C.D., Mabry, J.W., Bush,
        E.J., Seitzinger, A.H., Green, A.L. and J.J. Zimmerman. 2005.
        Assessment of the economic impact of porcine reproductive and
        respiratory syndrome on swine production in the United States. J Am
        Vet Med Assoc., 227 (3): 385-392.

    (3) Yoon K.Y., Zimmerman J.J., Chang C-C, Cancel Tirado S., Harmon K.M.,
        McGinley M.J.Yoon K-J, and C.C. Chang. 1999. Effect of challenge dose
        and route on porcine reproductive and respiratory syndrome virus
        (PRRSV) in young swine. Vet Res 30: 629-638.

    (4) Based on 23 weaned piglets per sow and including capital cost,
        interest, maintenance and repair expenses

    The information set forth in this press release includes certain
forward-looking statements. Such statements are based on assumptions exposed
to major risks and uncertainties. Although Noveko deems the expectations
reflected in these forward-looking statements to be reasonable, the Company
cannot provide any guarantee as to the materialization of the expectations
reflected in these forward-looking statements. The TSX Venture Exchange has
not reviewed and does not accept responsibility for the adequacy or accuracy
of this release.

For further information:

For further information: André Leroux, Chairman of the Board and Chief
Executive Officer; Alain Bolduc, President and Chief Operating Officer, Noveko
International Inc., (514) 344-3030,; Marie-Claude
Leroux, Morin Public Relations, (514) 289-8688, ext. 224, Cell: (514)

Organization Profile

Noveko International Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890